Autobio Diagnostics and Subsidiary Secure Four Medical Device Registrations

Stock News
05/19

Autobio Diagnostics Co.,Ltd. (603658.SH) has announced that the company and its wholly-owned subsidiary, Autobio Instruments (Zhengzhou) Co., Ltd., recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. A total of four products have obtained these registrations. They are: the fully automated chemiluminescence immunoassay analyzer (models: AutoLumo A6900, AutoLumo A9000, AutoLumo A9600), the Epstein-Barr virus capsid antigen IgM antibody detection kit (magnetic particle chemiluminescence method), the Mycoplasma pneumoniae nucleic acid and drug-resistant mutation site detection kit (PCR-fluorescence probe method), and the Interleukin-17A detection kit (magnetic particle chemiluminescence method).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10